Tag: ASCO

10 Highlights of the Year 2011 for the Carcinoid and Neuroendocrine Tumor Community

As the Carcinoid Cancer Foundation looks back on the year 2011, there were many significant events and advances for the carcinoid and neuroendocrine tumor (NET) community.  Here are 10 of the year’s important stories:

1)     The FDA approved the first…

ASCO Expressions of Hope: Now Accepting Artwork for 2011-2012 Calendar

Carcinoid and neuroendocrine cancer survivors and anyone who has been affected by cancer — patients, friends, families, caregivers — are invited by the American Society of Clinical Oncology (ASCO) to share their emotions through art …

Up-to-the-Minute: News for the Carcinoid and Neuroendocrine Tumor Community

The first device that simultaneously performs PET and MRI scans, a new alpha-emitter-based therapy for NET cancer patients with progressive therapy-resistant tumors, the first–ever randomized virtual clinical trial, over 100  abstracts on carcinoid…

Carcinoid Cancer Featured in ASCO 2011 Expressions of Hope Calendar

Carcinoid cancer is the focus of the April calendar page for the 2011 Expressions of Hope calendar published by the ASCO (American Society of Clinical Oncology) Cancer Foundation. The calendar illustrations have been created by cancer patients, family…

ASCO Calendar of Hope — Call for Artwork

Carcinoid and neuroendocrine cancer patients, and cancer survivors of all ages, are invited by the American Society of Clinical Oncology (ASCO) to share their emotions through art and inspire hope in others.  ASCO is accepting artwork submissions …